THERAMAX ALLERGY RELIEF ZINC FREE NASAL SPRAY
- Manufacturer
- THERABIOGEN | COSMEDX SCIENCE, INC.
- Effective date
- 2010-10-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:02:39
Label at a glance#
ProductTHERAMAX ALLERGY RELIEF NASAL
Active ingredientGREEN TEA LEAF, ONION, SODIUM CHLORIDE, STRYCHNOS NUX-VOMICA SEED, LUFFA OPERCULATA FRUIT, GALPHIMIA GLAUCA FLOWERING TOP, HISTAMINE DIHYDROCHLORIDE, SULFUR
Label structure15 sections
Contacts and useful links#
Websitewww.theramaxrelief.com
www.theramaxrelief.com
www.theramaxrelief.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts
Active Ingredients Purpose
Camellia Sinensis 3X Upper respiratory allergy symptom relief
Allium Cepa 6X Upper respiratory allergy symptom relief
Natrum Muriaticum 6X Upper respiratory allergy symptom relief
Nux Vomica 6X Upper respiratory allergy symptom relief
Luffa Oprculata 6X, 12X, 30X Upper respiratory allergy symptom relief
Galphimia Glauca 12X, 30X Upper respiratory allergy symptom relief
Histaminum Hydrochloricum 12X, 30X, 200X Upper respiratory allergy symptom relief
Sulphur 12X, 30X, 200X Upper respiratory allergy symptom relief
OTC - PURPOSE SECTION
Purpose:
Upper respiratory allergy symptom relief
INDICATIONS & USAGE SECTION
Uses
Relieves symptoms of hay fever and other upper respiratory allergies such as:
sneezing runny nose itchy, watery eyes nasal congestion sinus pressure
WARNINGS SECTION
Warnings
For nasal use only.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
ear nose or throat sensitivity
susceptibility to nose bleeds
OTC - WHEN USING SECTION
When using this product
Avoid contact with eyes. In case of accidental contact with eyes, flush with water and immediately seek professional help.
The use of this container by more than one person may spread infection.
OTC - STOP USE SECTION
Stop use and ask a doctor if symptoms persist
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
For best results, use at the first sign of allergy symptoms and continue to use for an additional 48 hours after symptoms subside.
Adults and children 6 years of age and older (with adult supervision):
Remove cap and safety clip (also see illustration on side carton and insert)
Hold with thumb at bottom of bottle and nozzle between your fingers. Before using the first time, prime pump by depressing several times.
Place tip of nozzle just past nasal opening (approximately 1/8")
While inside nasal opening, slightly angle nozzle outward.
Pump one to two times into each nostril
After application, press lightly on outside of each nostril for about 5 seconds.
Wait at least 30 seconds before blowing nose
Use once every 4 hours
Children under 6 years of age: Consult a doctor before use.
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Benzalkonium chloride, glycerin, hydroxyethylcellulose, potassium phosphate monobasic, sodium chloride, sodium phosphate dibasic, water
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
THERAMAX NDC 51445-201-15
Seasonal Allergy Relief
No known drug interactions
Non-drowsy
No jitters
Non-habit forming
Homeopathic
Satisfaction Guaranteed
Store at room temperature 15C-29C (59F-84F)
Product is naturally dark in color
Questions? Comments?
call 866-284-9561 or visit us on the web at
www. theramaxrelief.com
Developed and distributed by Therabiogen, Inc. (OTC: TRAB.OB)
(c)2008 Product of USA
HOMEOPATHIC
THERAMAX
ALLERGY RELIEF
ZINC FREE
NASAL SPRAY
Relief of
Sneezing
Runny Nose
Itchy, Watery Eyes
Nasal Congestion
Sinus Pressure
0.50 FL OZ (15ml) Homeopathic
DIRECTIONS
1. Remove cap and safety clip
2. Hold with thumb at bottom of bottle and nozzle between your fingers
3. Prior to initial use, prime pump by holding it upright and depressing several times (into a tissue) until the liquid is dispensed.
4. Place tip of nozzle just past nasal opening (approximately 1/8")
5. While inside nasal opening, slightly angle nozzle outward as shown
6. Pump one to two times into each nostril
7. After application, press lightly on the outside of each nostril for about 5 seconds.
HOMEOPATHIC
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Active Ingredients:
Camellia Sinensis 3X, Allium cepa 6X
Natrum Muriaticum 6X, Nux vornica 6X
Luffa Operculata 6X, 12X, 30X
Galphimia Glauca 12X, 30X
Histaminum Hydrochloricum 12X, 30X, 200X
Sulphur 12X, 30X, 200X
Note: Prior to using Theramax Allergy Relief, read the entire package
(c) Developed and distributed by Therabiogen, Inc. (OTC: TRABE.OB)
New York, NY 10005
PRODUCT OF USA
Theramax
Allergy Relief
Zinc Free
Nasal Spray
0.50 FL OZ. (15ml) HOMEOPATHIC
Do not use if tamper resistant seal is broken or missing.
Uses: Relieves symptoms of hay fever and other respiratory allergies such as, sneezing, runny nose, itchy watery eyes, nasal congestion and sinus pressure.
Questions or comments: Call 866-284-9561
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51445-201-15 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d172-8e05-e053-dbdaa90a074a | THERAMAX ALLERGY RELIEF ZINC FREE NASAL SPRAY |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51445-201-15 | THERAMAX ALLERGY RELIEF NASAL | 15 mL in 1 BOTTLE, SPRAY | SPRAY | 15 | 2 | |
| 51445-201-15 | THERAMAX ALLERGY RELIEF NASAL | 1 in 1 BOX | SPRAY | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51445-201 | THERAMAX ALLERGY RELIEF NASAL (CAMELLIA SINENSIS, ALLIUM CEPA, NATRUM MURIATICUM, NUX VOMICA, LUFFA OPERCULATA, GALPHIMIA GLAUCA, HISTAMINUM HYDROCHLORUM, SULPHUR) SPRAY [THERABIOGEN] | 2 | Legacy NDC, 2 package rows | 20101007_483028e5-1ad2-4f61-8f95-92705d41f986.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE INGREDIENT | 93PH5Q8M7E | 2 | |
| GREEN TEA LEAF | ACTIVE INGREDIENT | W2ZU1RY8B0 | 2 | |
| HISTAMINE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3POA0Q644U | 2 | |
| LUFFA OPERCULATA FRUIT | ACTIVE INGREDIENT | C4MO6809HU | 2 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 2 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE INGREDIENT | 269XH13919 | 2 | |
| SULFUR | ACTIVE INGREDIENT | 70FD1KFU70 | 2 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE MOIETY | 93PH5Q8M7E | 2 | |
| GREEN TEA LEAF | ACTIVE MOIETY | W2ZU1RY8B0 | 2 | |
| HISTAMINE | ACTIVE MOIETY | 820484N8I3 | 2 | |
| LUFFA OPERCULATA FRUIT | ACTIVE MOIETY | C4MO6809HU | 2 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 2 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 2 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE MOIETY | 269XH13919 | 2 | |
| SULFUR | ACTIVE MOIETY | 70FD1KFU70 | 2 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| POTASSIUM PHOSPHATE, MONOBASIC | INACTIVE INGREDIENT | 4J9FJ0HL51 | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| SODIUM PHOSPHATE, DIBASIC | INACTIVE INGREDIENT | GR686LBA74 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- THERAMAX ALLERGY RELIEF NASAL
- CAMELLIA SINENSIS, ALLIUM CEPA, NATRUM MURIATICUM, NUX VOMICA, LUFFA OPERCULATA, GALPHIMIA GLAUCA, HISTAMINUM HYDROCHLORUM, SULPHUR
- GREEN TEA LEAF
- ONION
- SODIUM CHLORIDE
- SODIUM CATION
- STRYCHNOS NUX-VOMICA SEED
- LUFFA OPERCULATA FRUIT
- GALPHIMIA GLAUCA FLOWERING TOP
- HISTAMINE DIHYDROCHLORIDE
- HISTAMINE
- SULFUR
- BENZALKONIUM CHLORIDE
- GLYCERIN
- POTASSIUM PHOSPHATE, MONOBASIC
- SODIUM PHOSPHATE, DIBASIC
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 51445-201 | 51445-201-15 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GREEN TEA LEAF | W2ZU1RY8B0 | ACTIB |
| ONION | 492225Q21H | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| STRYCHNOS NUX-VOMICA SEED | 269XH13919 | ACTIB |
| LUFFA OPERCULATA FRUIT | C4MO6809HU | ACTIB |
| GALPHIMIA GLAUCA FLOWERING TOP | 93PH5Q8M7E | ACTIB |
| HISTAMINE DIHYDROCHLORIDE | 3POA0Q644U | ACTIB |
| SULFUR | 70FD1KFU70 | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POTASSIUM PHOSPHATE, MONOBASIC | 4J9FJ0HL51 | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVENOUS | 0.9 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY / NASAL | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATHECAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / OPHTHALMIC | 2 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / TOPICAL | 0.18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| POTASSIUM PHOSPHATE, MONOBASIC | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | TABLET / ORAL | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / TOPICAL | 0.86 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVENOUS | 28773 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | GEL / OPHTHALMIC | 0.01 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SOFT TISSUE | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, COATED / ORAL | 54.7 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / SUBCUTANEOUS | 90 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRA-ARTICULAR | 1 mg | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / INTRAMUSCULAR | 40 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | FILM, SOLUBLE / ORAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTICULAR | 26 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 40 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | OINTMENT / TOPICAL | 0.03 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUPPOSITORY / RECTAL | 140 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1800 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAMUSCULAR | 1486 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / ENDOTRACHEAL | 68 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / EPIDURAL | 3535 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / AURICULAR (OTIC) | 0.01 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| POTASSIUM PHOSPHATE, MONOBASIC | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SOLUTION / ORAL | 287 mg | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / INTRADERMAL | 0.2 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRATHECAL | 1.35 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 360 mg | ||
| POTASSIUM PHOSPHATE, MONOBASIC | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| POTASSIUM PHOSPHATE, MONOBASIC | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SUSPENSION / ORAL | 50 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / RESPIRATORY (INHALATION) | 43 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 450d394b-f4ce-4139-9aa5-c6b6d27caef2 | 483028e5-1ad2-4f61-8f95-92705d41f986 | 2010-10-06 | Warnings | 450d394b-f4ce-4139-9aa5-c6b6d27caef2 483028e5-1ad2-4f61-8f95-92705d41f986 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.